Emla (EMLA) Lyfjaplástur 25+25 mg/plástur Исландия - исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

emla (emla) lyfjaplástur 25+25 mg/plástur

aspen pharma trading limited - lidocainum inn; prilocainum inn - lyfjaplástur - 25+25 mg/plástur

Qaialdo Европейски съюз - исландски - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.

Gaviscon Mixtúra, dreifa Исландия - исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

gaviscon mixtúra, dreifa

nordic drugs ab - calcii carbonas; aluminii hydroxidum; natrii hydrogenocarbonas; natrii alginas - mixtúra, dreifa